0001293577-17-000001.txt : 20170123
0001293577-17-000001.hdr.sgml : 20170123
20170123153209
ACCESSION NUMBER: 0001293577-17-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170119
FILED AS OF DATE: 20170123
DATE AS OF CHANGE: 20170123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katz Richard D
CENTRAL INDEX KEY: 0001293577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 17540981
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-01-19
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001293577
Katz Richard D
4505 EMPEROR BOULEVARD
SUITE 300
DURHAM
NC
27703
0
1
0
0
VP & Chief Financial Officer
Common Stock
2017-01-19
4
A
0
3958
0
A
3958
D
Stock Option (right to buy)
4.85
2017-01-19
4
A
0
105000
0
A
2027-01-18
Common Stock
105000
105000
D
This option was granted on January 19, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.
/s/ Lori R. Harrelson, attorney-in-fact
2017-01-23